Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.ejpb.2021.05.011 http://hdl.handle.net/11449/233175 |
Resumo: | Nanotechnology has been widely applied to develop drug delivery systems to improve therapeutic performance. The effectiveness of these systems is intrinsically related to their physicochemical properties, so their biological responses are highly susceptible to factors such as the type and quantity of each material that is employed in their synthesis and to the method that is used to produce them. In this context, quality-oriented manufacturing of nanoparticles has been an important strategy to understand and to optimize the factors involved in their production. For this purpose, Design of Experiment (DoE) tools have been applied to obtain enough knowledge about the process and hence achieve high-quality products. This review aims to set up the bases to implement DoE as a strategy to improve the manufacture of nanocarriers and to discuss the main factors involved in the production of the most common nanocarriers employed in the pharmaceutical field. |
id |
UNSP_35ce44cb2ed72bb2f3cdf65241574f3e |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/233175 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systemsBox-Behnken DesignCentral Composite DesignFractional Factorial DesignFull Factorial DesignNanomedicineNanotechnologyPlackett-Burman DesignQuality by DesignResponse Surface MethodologyNanotechnology has been widely applied to develop drug delivery systems to improve therapeutic performance. The effectiveness of these systems is intrinsically related to their physicochemical properties, so their biological responses are highly susceptible to factors such as the type and quantity of each material that is employed in their synthesis and to the method that is used to produce them. In this context, quality-oriented manufacturing of nanoparticles has been an important strategy to understand and to optimize the factors involved in their production. For this purpose, Design of Experiment (DoE) tools have been applied to obtain enough knowledge about the process and hence achieve high-quality products. This review aims to set up the bases to implement DoE as a strategy to improve the manufacture of nanocarriers and to discuss the main factors involved in the production of the most common nanocarriers employed in the pharmaceutical field.School of Pharmaceutical Sciences of Ribeirao Preto University of Sao PauloDepartment of Computer Science Federal University of Minas Gerais, Belo HorizonteSchool of Pharmaceutical Sciences Sao Paulo State UniversityDepartment of Chemistry Faculty of Philosophy Sciences and Letters of Ribeirao Preto University of São PauloSchool of Pharmaceutical Sciences Sao Paulo State UniversityUniversidade de São Paulo (USP)Universidade Federal de Minas Gerais (UFMG)Universidade Estadual Paulista (UNESP)Tavares Luiz, MarcelaSantos Rosa Viegas, JulianaPalma Abriata, JulianaViegas, FelipeTesta Moura de Carvalho Vicentini, FabianaLopes Badra Bentley, Maria VitóriaChorilli, Marlus [UNESP]Maldonado Marchetti, JulianaTapia-Blácido, Delia Rita2022-05-01T05:29:28Z2022-05-01T05:29:28Z2021-08-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article127-148http://dx.doi.org/10.1016/j.ejpb.2021.05.011European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 127-148.1873-34410939-6411http://hdl.handle.net/11449/23317510.1016/j.ejpb.2021.05.0112-s2.0-85108303638Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEuropean Journal of Pharmaceutics and Biopharmaceuticsinfo:eu-repo/semantics/openAccess2024-06-24T13:45:19Zoai:repositorio.unesp.br:11449/233175Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T15:41:43.461040Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems |
title |
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems |
spellingShingle |
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems Tavares Luiz, Marcela Box-Behnken Design Central Composite Design Fractional Factorial Design Full Factorial Design Nanomedicine Nanotechnology Plackett-Burman Design Quality by Design Response Surface Methodology |
title_short |
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems |
title_full |
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems |
title_fullStr |
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems |
title_full_unstemmed |
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems |
title_sort |
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems |
author |
Tavares Luiz, Marcela |
author_facet |
Tavares Luiz, Marcela Santos Rosa Viegas, Juliana Palma Abriata, Juliana Viegas, Felipe Testa Moura de Carvalho Vicentini, Fabiana Lopes Badra Bentley, Maria Vitória Chorilli, Marlus [UNESP] Maldonado Marchetti, Juliana Tapia-Blácido, Delia Rita |
author_role |
author |
author2 |
Santos Rosa Viegas, Juliana Palma Abriata, Juliana Viegas, Felipe Testa Moura de Carvalho Vicentini, Fabiana Lopes Badra Bentley, Maria Vitória Chorilli, Marlus [UNESP] Maldonado Marchetti, Juliana Tapia-Blácido, Delia Rita |
author2_role |
author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade de São Paulo (USP) Universidade Federal de Minas Gerais (UFMG) Universidade Estadual Paulista (UNESP) |
dc.contributor.author.fl_str_mv |
Tavares Luiz, Marcela Santos Rosa Viegas, Juliana Palma Abriata, Juliana Viegas, Felipe Testa Moura de Carvalho Vicentini, Fabiana Lopes Badra Bentley, Maria Vitória Chorilli, Marlus [UNESP] Maldonado Marchetti, Juliana Tapia-Blácido, Delia Rita |
dc.subject.por.fl_str_mv |
Box-Behnken Design Central Composite Design Fractional Factorial Design Full Factorial Design Nanomedicine Nanotechnology Plackett-Burman Design Quality by Design Response Surface Methodology |
topic |
Box-Behnken Design Central Composite Design Fractional Factorial Design Full Factorial Design Nanomedicine Nanotechnology Plackett-Burman Design Quality by Design Response Surface Methodology |
description |
Nanotechnology has been widely applied to develop drug delivery systems to improve therapeutic performance. The effectiveness of these systems is intrinsically related to their physicochemical properties, so their biological responses are highly susceptible to factors such as the type and quantity of each material that is employed in their synthesis and to the method that is used to produce them. In this context, quality-oriented manufacturing of nanoparticles has been an important strategy to understand and to optimize the factors involved in their production. For this purpose, Design of Experiment (DoE) tools have been applied to obtain enough knowledge about the process and hence achieve high-quality products. This review aims to set up the bases to implement DoE as a strategy to improve the manufacture of nanocarriers and to discuss the main factors involved in the production of the most common nanocarriers employed in the pharmaceutical field. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-08-01 2022-05-01T05:29:28Z 2022-05-01T05:29:28Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.ejpb.2021.05.011 European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 127-148. 1873-3441 0939-6411 http://hdl.handle.net/11449/233175 10.1016/j.ejpb.2021.05.011 2-s2.0-85108303638 |
url |
http://dx.doi.org/10.1016/j.ejpb.2021.05.011 http://hdl.handle.net/11449/233175 |
identifier_str_mv |
European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 127-148. 1873-3441 0939-6411 10.1016/j.ejpb.2021.05.011 2-s2.0-85108303638 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
European Journal of Pharmaceutics and Biopharmaceutics |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
127-148 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808128551101136896 |